American Cannabis Company, Inc.
AMMJ · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.06 | -0.04 | 0.96 |
| FCF Yield | -7.65% | -12.61% | -23.79% | -12.87% |
| EV / EBITDA | -0.67 | -10.94 | -4.80 | -4.82 |
| Quality | ||||
| ROIC | -331.57% | -19.33% | -47.02% | -35.92% |
| Gross Margin | 42.08% | 13.49% | 43.55% | 45.90% |
| Cash Conversion Ratio | 0.01 | 0.31 | 0.67 | 0.99 |
| Growth | ||||
| Revenue 3-Year CAGR | 0.70% | 128.82% | 4.40% | 16.92% |
| Free Cash Flow Growth | 72.94% | 77.14% | -150.73% | -273.47% |
| Safety | ||||
| Net Debt / EBITDA | -0.34 | -3.62 | -0.41 | 3.12 |
| Interest Coverage | -33.90 | -7.76 | -21.77 | -349.38 |
| Efficiency | ||||
| Inventory Turnover | 2.45 | 46.10 | 4.91 | 13.61 |
| Cash Conversion Cycle | -73.50 | 1.79 | 11.28 | 26.97 |